APOC2 and hypertriglyceridemia: Although the mechanisms causing hypertriglyceridemia are not fully understood, certain genetic mutations, such as Apolipoprotein E mutations, APOA5 mutation, and APOC2 mutation, may be involved, leading to protein defects and function loss (24).